This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Noriyasu Katoh: Innovator in Pharmaceutical Chemistry
Introduction
Noriyasu Katoh is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on dipeptidyl peptidase IV inhibitors. His research focuses on developing compounds that exhibit high activity, stability, and safety as pharmaceutical agents.
Latest Patents
Noriyasu Katoh holds a patent for a compound inhibiting dipeptidyl peptidase IV. This compound is characterized by its excellent action as a pharmaceutical agent. The patent describes a compound represented by a specific general formula, which includes various substituents and functional groups that enhance its efficacy.
Career Highlights
Katoh is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been instrumental in advancing research in pharmaceutical compounds. His work has contributed to the development of new therapeutic agents that can potentially improve patient outcomes.
Collaborations
Throughout his career, Noriyasu Katoh has collaborated with esteemed colleagues, including Takuji Kakigami and Mitsuru Oka. These collaborations have fostered a productive research environment, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Noriyasu Katoh's contributions to pharmaceutical chemistry, particularly in the development of dipeptidyl peptidase IV inhibitors, highlight his role as a significant inventor in the field. His work continues to influence the development of effective pharmaceutical agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile